Trimethyltin chloride exposure induces cardiac malformations by activating ferroptosis through the NOX4/Keap1/Nrf2/ROS signaling pathway in zebrafish embryos.
Does inhibition of the NOX4/Keap1/Nrf2/ROS pathway or ferroptosis prevent TMT-induced cardiac developmental malformations in zebrafish embryos?
Trimethyltin chloride induces cardiac developmental malformations by activating ferroptosis via the NOX4/Keap1/Nrf2/ROS signaling axis, revealing a novel mechanism of cardiotoxicity and potential therapeutic targets.
Absolute Event Rate: 0% vs 0%
Trimethyltin chloride (TMT), a pervasive environmental organic tin pollutant, has been implicated in cardiac injury, though its underlying mechanisms remain unclear. TMT exposure triggers excessive reactive oxygen species (ROS) generation, a key inducer of ferroptosis-a regulated form of cell death driven by iron-dependent lipid peroxidation. NADPH oxidase 4 (NOX4), highly expressed during cardiac development, plays a critical role in myocardial ROS production, while the Keap1/Nrf2 pathway regulates cellular ROS homeostasis. We hypothesized that TMT induces cardiac developmental defects by activating NOX4/Keap1/ROS-mediated ferroptosis. TMT exposure induced cardiac malformations, pericardial edema, and reduced heart rate in zebrafish embryos. Further studies revealed that TMT upregulated nox4 expression in embryonic hearts. Notably, pharmacological inhibition or genetic knockdown of nox4 markedly attenuated TMT-induced cardiac defects. Moreover, nox4 suppression antagonized TMT-triggered dysregulation of the Keap1/Nrf2 axis, ROS overaccumulation, mitochondrial damage, and ferroptosis-related abnormalities-including Fe²⁺ accumulation, elevated lipid peroxidation, and downregulated glutathione peroxidase 4 (GPX4) expression. Crucially, inhibition or knockdown of keap1 similarly mitigated TMT-induced ROS bursts, mitochondrial injury, and ferroptosis progression. Intervention with ferroptosis-specific inhibitors (Liproxstatin-1 and Myricetin) confirmed that ferroptosis directly contributes to TMT-induced cardiac developmental defects. This study demonstrates that TMT induces cardiac malformations by activating ferroptosis via the nox4/Keap1/Nrf2/ROS signaling axis. These findings reveal a novel mechanism underlying TMT cardiotoxicity, provide theoretical insights for assessing TMT exposure as a risk factor for congenital heart disease, and identify potential molecular targets for therapeutic intervention.
Chen et al. (Fri,) reported a other. Trimethyltin chloride exposure induces cardiac malformations by activating ferroptosis through the NOX4/Keap1/Nrf2/ROS signaling pathway in zebrafish embryos.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: